4691 - 4700 of 9140 Results
Title
Year
- Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's disease2018RESTRICTEDTitle: Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's diseaseJournal Name: European Journal of Medical GeneticsPublisher: Elsevier BVVol: 62Issue #: 1Start Page: 65End Page: 69Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejmg.2018.05.005Citation Count: 69
-
OPENTitle: Patient-centred management of Parkinson's disease – Authors' replyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 889End Page: 890Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30360-4Best OA location URL: http://www.thelancet.com/article/S1474442220303604/pdfCitation Count: 0
- Animal exposure over the life-course and risk of multiple sclerosis: A case-control study within two cohorts of US women2018OPENTitle: Animal exposure over the life-course and risk of multiple sclerosis: A case-control study within two cohorts of US womenJournal Name: Multiple Sclerosis and Related DisordersPublisher: Elsevier BVVol: 27Issue #:Start Page: 327End Page: 332Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.msard.2018.11.015Citation Count: 5
- New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease2010RESTRICTEDTitle: New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page: S104End Page: 9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22636Citation Count: 45
- The Lysosome and Nonmotor Symptoms: Linking Parkinson's Disease and Lysosomal Storage Disorders2020RESTRICTEDTitle: The Lysosome and Nonmotor Symptoms: Linking Parkinson's Disease and Lysosomal Storage DisordersJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 12Start Page: 2150End Page: 2155Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28232Citation Count: 7
- MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson’s Disease Patients2018RESTRICTEDTitle: MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson’s Disease PatientsJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 56Issue #: 3Start Page: 2092End Page: 2100Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12035-018-1219-1Citation Count: 23
- Hybrid deep brain stimulation system to manage stimulation-induced side effects in essential tremor patients2018RESTRICTEDTitle: Hybrid deep brain stimulation system to manage stimulation-induced side effects in essential tremor patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 58Issue #:Start Page: 85End Page: 86Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.07.013Citation Count: 16
-
OPENTitle: TrkB neurotrophic activities are blocked by α-synuclein, triggering dopaminergic cell death in Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 114Issue #: 40Start Page: 10773End Page: 10778Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1713969114Best OA location URL: https://www.pnas.org/content/pnas/114/40/10773.full.pdfCitation Count: 133
-
OPENTitle: Splice-Switching Antisense Oligonucleotides Reduce LRRK2 Kinase Activity in Human LRRK2 Transgenic MiceJournal Name: Molecular Therapy Nucleic AcidsPublisher: Elsevier BVVol: 21Issue #:Start Page: 623End Page: 635Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.omtn.2020.06.027Best OA location URL: http://www.cell.com/article/S2162253120301888/pdfCitation Count: 46
- Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease2016RESTRICTEDTitle: Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 113Issue #:Start Page: 110End Page: 123Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.09.028Citation Count: 64